| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
35,410,000 |
| Market
Cap: |
14.14(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$202.16 - $413.31 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 463 |
| Guru Rank Value : 3 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Medpace Holdings is a holding company. Through its subsidiaries, Co. is a clinical contract research organization focused on providing scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Co. provides a suite of services supporting the clinical development process from Phase I to Phase IV across a range of therapeutic areas. Co.'s services include medical department, clinical trial management, study start-up, patient recruitment and retention, clinical monitoring, risk-based monitoring, regulatory affairs, medical writing, biometrics and data sciences, pharmacovigilance, and quality assurance.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
2,000,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$309,116,534 |
| Total People Bought |
0 |
0 |
0 |
2 |
| Total Buy Transactions |
0 |
0 |
0 |
34 |
| Total Shares Sold |
1,827,736 |
2,490,136 |
3,605,616 |
3,694,042 |
| Total Sell Value |
$734,360,254 |
$918,029,204 |
$1,190,266,600 |
$1,209,941,112 |
| Total People Sold |
6 |
6 |
8 |
8 |
| Total Sell Transactions |
45 |
71 |
88 |
95 |
| End Date |
2024-02-10 |
2023-11-09 |
2023-05-11 |
2022-05-11 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Troendle August J. |
CEO |
• • • |
2023-11-20 |
4 |
S |
$275.45 |
$13,772,500 |
I/I |
(50,000) |
5,739,947 |
|
-42% |
|
| Medpace Investors, Llc |
|
• • • |
2023-11-20 |
4 |
S |
$275.45 |
$13,772,500 |
D/D |
(50,000) |
5,739,947 |
|
-42% |
|
| Troendle August J. |
CEO |
• • • |
2023-11-17 |
4 |
S |
$273.91 |
$13,695,500 |
I/I |
(50,000) |
5,789,947 |
|
-45% |
|
| Medpace Investors, Llc |
|
• • • |
2023-11-17 |
4 |
S |
$273.91 |
$13,695,500 |
D/D |
(50,000) |
5,789,947 |
|
-45% |
|
| Troendle August J. |
CEO |
• • • |
2023-11-16 |
4 |
S |
$281.61 |
$4,787,370 |
I/I |
(17,000) |
5,839,947 |
|
-44% |
|
| Medpace Investors, Llc |
|
• • • |
2023-11-16 |
4 |
S |
$281.61 |
$4,787,370 |
D/D |
(17,000) |
5,839,947 |
|
-44% |
|
| Troendle August J. |
CEO |
• • • |
2023-11-15 |
4 |
S |
$283.42 |
$9,352,860 |
I/I |
(33,000) |
5,856,947 |
|
-43% |
|
| Medpace Investors, Llc |
|
• • • |
2023-11-15 |
4 |
S |
$283.42 |
$9,352,860 |
D/D |
(33,000) |
5,856,947 |
|
-43% |
|
| Troendle August J. |
CEO |
• • • |
2023-11-14 |
4 |
S |
$283.11 |
$7,077,750 |
I/I |
(25,000) |
5,889,947 |
|
-43% |
|
| Medpace Investors, Llc |
|
• • • |
2023-11-14 |
4 |
S |
$283.11 |
$7,077,750 |
D/D |
(25,000) |
5,889,947 |
|
-43% |
|
| Burwig Susan E |
Exec. VP, Operations |
• • – |
2023-10-23 |
4 |
OE |
$32.05 |
$240,375 |
D/D |
7,500 |
27,683 |
|
- |
|
| Mccarthy Cornelius P. Iii |
|
• • – |
2023-09-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
82 |
246 |
|
- |
|
| Kraft Robert O. |
|
• • – |
2023-09-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
94 |
282 |
|
- |
|
| Carley Brian T |
|
• • – |
2023-09-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
103 |
7,710 |
|
- |
|
| Troendle August J. |
CEO |
• • • |
2023-09-21 |
4 |
AS |
$244.27 |
$15,060,467 |
I/I |
(61,655) |
5,914,947 |
|
21% |
|
| Medpace Investors, Llc |
|
– – • |
2023-09-21 |
4 |
AS |
$244.27 |
$15,060,467 |
D/D |
(61,655) |
5,914,947 |
|
21% |
|
| Troendle August J. |
CEO |
• • • |
2023-09-20 |
4 |
AS |
$255.48 |
$16,773,028 |
I/I |
(65,653) |
5,976,602 |
|
19% |
|
| Medpace Investors, Llc |
|
– – • |
2023-09-20 |
4 |
AS |
$255.48 |
$16,773,028 |
D/D |
(65,653) |
5,976,602 |
|
19% |
|
| Medpace Investors, Llc |
|
• • • |
2023-09-19 |
4 |
AS |
$259.66 |
$35,671,831 |
D/D |
(137,379) |
6,042,255 |
|
18% |
|
| Troendle August J. |
CEO |
• • • |
2023-09-19 |
4 |
AS |
$259.66 |
$35,671,831 |
I/I |
(137,379) |
6,042,255 |
|
18% |
|
| Medpace Investors, Llc |
|
• • • |
2023-09-18 |
4 |
AS |
$274.76 |
$14,668,063 |
D/D |
(53,385) |
6,179,634 |
|
9% |
|
| Troendle August J. |
CEO |
• • • |
2023-09-18 |
4 |
AS |
$274.76 |
$14,668,063 |
I/I |
(53,385) |
6,179,634 |
|
9% |
|
| Kraft Robert O. |
|
• • – |
2023-08-14 |
4 |
S |
$265.67 |
$3,661,464 |
D/D |
(13,782) |
188 |
|
-14% |
|
| Kraft Robert O. |
|
• • – |
2023-08-14 |
4 |
OE |
$26.44 |
$364,396 |
D/D |
13,782 |
13,970 |
|
- |
|
| Brady Kevin M. |
CFO & Treasurer |
• • – |
2023-07-31 |
4 |
S |
$255.00 |
$1,785,000 |
D/D |
(7,000) |
6,000 |
|
-10% |
|
542 Records found
|
|
Page 4 of 22 |
|
|
11.59 (2.99%) 
